Drug Trial Radar · NCT02128763
Dry Eye Assessment and Management Study
Last checked: Nov 20, 2026Latest source record: Jul 19, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
535
Actual
Start
Nov 2014
Primary completion
Sep 5, 2017
Study completion Jan 31, 2020
Sponsor
- Lead sponsor
- University of PennsylvaniaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Eye Institute (NEI)
- First posted
- May 1, 2014
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of the DREAM study is to evaluate the effectiveness and safety of supplementation with omega-3 fatty acids in relieving the symptoms of moderate to severe dry eye disease.
Conditions
- Dry Eye
Interventions
Omega-3 supplementsDrug
2000 mg EPA and 1000 mg DHA per day
PlaceboDrug
Olive oil gelcaps manufactured to mimic Omega-3 gelcaps
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean of Change From Baseline in Ocular Surface Disease Index (OSDI) Score at 6 and 12 MonthsTime frame: 12 months
Locations
27 sites in 1 country. Site status is shown where the registry gives one.
Stephen Cohen, OD PC
Scottsdale, Arizona
Mayo Clinic Arizona
Scottsdale, Arizona
Milton M. Hom, OD, FAAO
Azusa, California
University of California, Berkeley
Berkeley, California
Pendleton Eye Center
Oceanside, California
Wolstan and Goldberg Eye Associates
Torrance, California
Shettle Eye Research
Largo, Florida
Eye Care Centers Management, Inc.
Morrow, Georgia
University of Illinois Hospital & Health Sciences
Chicago, Illinois
Price Vision Group
Indianapolis, Indiana
KU Eye Center
Prairie Village, Kansas
Tufts Medical Center
Boston, Massachusetts
Massachusetts Eye and Ear Infirmary
Boston, Massachusetts
Clinical Eye Research of Boston
Winchester, Massachusetts
University of Michigan Kellogg Eye Center
Ann Arbor, Michigan
Minnesota Eye Consultants, P.A.
Bloomington, Minnesota
Mulqueeny Eye Centers
Creve Coeur, Missouri
Tauber Eye Center
Kansas City, Missouri
Silverstein Eye Centers
Kansas City, Missouri
Icahn School of Medicine at Mount Sinai
New York, New York
Universtity of Rochester-Flaum Eye Institute
Rochester, New York
Oculus Research at Garner at Eyecarecenter
Raleigh, North Carolina
Case Western Reserve University
Cleveland, Ohio
Northeast Ohio Eye Surgeons
Kent, Ohio
Scheie Eye Institute, University of Pennsylvania
Philadelphia, Pennsylvania
Southern College of Optometry
Memphis, Tennessee
The Eye Centers of Racine and Kenosha
Racine, Wisconsin
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.